Filing Details
Nuvation Bio Inc. (NYSE:NUVB) filed a Form 8-K with the Securities and Exchange Commission on June 30, 2026, disclosing a material event.
8k filedNYSE:NUVB
Nuvation Bio Inc. (NUVB) Reports Material Event to SEC
Filing Details Nuvation Bio Inc. (NYSE:NUVB) filed a Form 8-K with the Securities and Exchange Commission on June 30, 2026, disclosing a material event. Market Context Nuvation…
Market Context
Nuvation Bio Inc.'s stock currently trades at $5.68 with a market capitalization of $2.8B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Nuvation Bio Inc.'s stock.
All SEC filings for Nuvation Bio Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View NUVB Stock Page
Frequently Asked Questions
Where can I read NUVB's SEC filings?
Browse all filings on our NUVB SEC filings page.
What types of SEC filings does Nuvation Bio Inc. file?
Public companies like Nuvation Bio Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.